Testosterone treatment of excessively tall boys
- 1 January 1976
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 88 (1), 116-123
- https://doi.org/10.1016/s0022-3476(76)80742-1
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- ANDROGEN-INDUCED HEPATOMAThe Lancet, 1975
- Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height.Archives of Disease in Childhood, 1975
- Hepatoma associated with androgen therapy for aplastic anemiaThe Journal of Pediatrics, 1974
- ANDROGENS AND HEPATOCELLULAR CARCINOMAThe Lancet, 1973
- ANDROGENIC STEROIDS AND HEPATOCELLULAR CARCINOMAThe Lancet, 1973
- ASSOCIATION OF ANDROGENIC-ANABOLIC STEROID THERAPY WITH DEVELOPMENT OF HEPATOCELLULAR CARCINOMAThe Lancet, 1972
- Hepatoma and Peliosis Hepatis Developing in a Patient with Fanconi's AnemiaNew England Journal of Medicine, 1971
- THE METABOLISM OF [1,2-3H]17α-METHYLTESTOSTERONE IN HUMAN SUBJECTSJournal of Endocrinology, 1967
- Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.JCI Insight, 1966
- Tables for predicting adult height from skeletal age: Revised for use with the greulich-pyle hand standardsThe Journal of Pediatrics, 1952